VELCADEĀ® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.
I keep hearing about Velcade being available subQ, but very few local oncologists know about this and the research they can locate is sparse. Any information out there? Best places to locate such information?
I keep hearing about Velcade being available subQ, but very few local oncologists know about this and the research they can locate is sparse. Any information out there? Best places to locate such information?
Leave a comment